The role of hyperinsulinemia in the pathogenesis of ovarian hyperandrogenism
- PMID: 3294042
- DOI: 10.1016/s0015-0282(16)60060-2
The role of hyperinsulinemia in the pathogenesis of ovarian hyperandrogenism
Abstract
The evidence that supports the hypothesis that insulin and LH both regulate ovarian androgen production was presented. The most dramatic clinical example of the association between hyperinsulinemia and hyperandrogenism is the HAIR-AN syndrome. Our hypothesis is that, in the HAIR-AN syndrome, the severe insulin resistance causes a compensatory hyperinsulinemia, which stimulates ovarian androgen production if adequate LH is present. The acanthosis nigricans is an epiphenomenon of the syndrome. Acanthosis nigricans is a dermatologic manifestation of severe insulin resistance. In vitro evidence suggests that insulin and IGF-I stimulate androgen production in incubations of human stroma and theca. The stromatropic effects of insulin may sensitize the stroma to the stimulatory effects of LH. In some hyperandrogenic-insulin-resistant women, a glucose load appears to produce an acute rise in circulating androgens. The magnitude of the rise in circulating androgens is proportional to the magnitude of the insulin response to the glucose load. These data suggest that hyperinsulinemia may play a central role in the development of ovarian hyperandrogenism.
Similar articles
-
Hyperinsulinemia and ovarian hyperandrogenism. Cause and effect.Endocrinol Metab Clin North Am. 1988 Dec;17(4):685-703. Endocrinol Metab Clin North Am. 1988. PMID: 3058472 Review.
-
Insulin stimulates androgen accumulation in incubations of human ovarian stroma and theca.Obstet Gynecol. 1984 Sep;64(3 Suppl):73S-80S. doi: 10.1097/00006250-198409001-00019. Obstet Gynecol. 1984. PMID: 6382082
-
Hyperandrogenism, insulin resistance and acanthosis nigricans. 10 years of progress.J Reprod Med. 1994 May;39(5):327-36. J Reprod Med. 1994. PMID: 8064699 Review.
-
Hyperandrogenism, insulin resistance, and acanthosis nigricans syndrome: a common endocrinopathy with distinct pathophysiologic features.Am J Obstet Gynecol. 1983 Sep 1;147(1):90-101. doi: 10.1016/0002-9378(83)90091-1. Am J Obstet Gynecol. 1983. PMID: 6351620 Review.
-
Polycystic ovary syndrome and the androgen-insulin connection.Am J Obstet Gynecol. 1991 Aug;165(2):346-8. doi: 10.1016/0002-9378(91)90089-a. Am J Obstet Gynecol. 1991. PMID: 1872336
Cited by
-
Identification of a functional polymorphism of the human type 5 17beta-hydroxysteroid dehydrogenase gene associated with polycystic ovary syndrome.J Clin Endocrinol Metab. 2006 Jan;91(1):270-6. doi: 10.1210/jc.2005-2012. Epub 2005 Nov 1. J Clin Endocrinol Metab. 2006. PMID: 16263811 Free PMC article.
-
Women's health and enhancing generalism in internal medicine.J Gen Intern Med. 1995 Aug;10(8):451-4. doi: 10.1007/BF02599917. J Gen Intern Med. 1995. PMID: 7472702 Review. No abstract available.
-
Autophagy in ovary and polycystic ovary syndrome: role, dispute and future perspective.Autophagy. 2021 Oct;17(10):2706-2733. doi: 10.1080/15548627.2021.1938914. Epub 2021 Jun 23. Autophagy. 2021. PMID: 34161185 Free PMC article. Review.
-
Interrelation between sex hormones and plasma sex hormone-binding globulin and hemoglobin A1c in healthy postmenopausal women.Metab Syndr Relat Disord. 2009 Jun;7(3):249-54. doi: 10.1089/met.2008.0081. Metab Syndr Relat Disord. 2009. PMID: 19344226 Free PMC article. Clinical Trial.
-
Changes of androgens levels in menopausal women.Prz Menopauzalny. 2020 Dec;19(4):151-154. doi: 10.5114/pm.2020.101941. Epub 2021 Jan 7. Prz Menopauzalny. 2020. PMID: 33488324 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources